Rompaleder and Rebac develop anti-infective leather
Netherlands-based Rompaleder Ltd, in conjunction with its German licensee Rebac GmbH, has developed a method of applying an anti-infection product into shoe leather to reduce foot infections. Representatives of both companies will present this new product at Lineapelle in
The product employs a biophysical method using Rebac’s highly developed equipment to create a permanent anti-myotic and antibacterial atmosphere inside the shoe. It reduces the risk of re-infection and also solves the problem of offensive odours. It is claimed that this method can banish bacteria and fungus from shoes permanently.
As 60% of the world’s population and 90% of athletes suffer from mycosis between the toes and on the feet, it is believed that there is a large market for this product.
Fungus and bacteria are also a big additional risk for sufferers of diabetes (now the world’s second most common disease). People who wear the same shoes each day, such as soldiers, or workers who wear safety shoes, often suffer with fungal and bacterial diseases. Sportsmen and women, especially runners and football players, often wear the same shoes for months on end; and spend hours surrounded by contagious fungus and are bacteria every day in areas such as swimming pools, gymnasiums, showers and dressing rooms. If shoes are treated with an anti-infective product, the risk of infection and re-infection is reduced.
According to the Rompaleder and Rebac, this method can, in principle, be applied to all types of leathers, including military, everyday, sports, and safety shoes.
